Drug reference

teplizumab-mzwv

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 1417

Review source pages for extracted sections and age labels.

Overview

Names and pronunciation

Tzield

PDF page 1417

Functional class

Func. class.: Antidiabetic

PDF page 1417

Uses

USES: To delay the onset of stage 3 type 1 diabetes (T1D) in adults and pedi- atric patients aged 8 yr and older with stage 2 T1D

PDF page 1417

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES See manufacturer’s information

PDF page 1417

Available forms

Available forms: Injection: 2 mg per 2 mL (1 mg/mL) single-dose vial APPENDIX A

PDF page 1417

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

Drug reference

teplizumab-mzwv

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 1417

Review source pages for extracted sections and age labels.

Overview

Names and pronunciation

Tzield

PDF page 1417

Functional class

Func. class.: Antidiabetic

PDF page 1417

Uses

USES: To delay the onset of stage 3 type 1 diabetes (T1D) in adults and pedi- atric patients aged 8 yr and older with stage 2 T1D

PDF page 1417

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES See manufacturer’s information

PDF page 1417

Available forms

Available forms: Injection: 2 mg per 2 mL (1 mg/mL) single-dose vial APPENDIX A

PDF page 1417

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

teplizumab-­mzwv

Overview

Names and pronunciation

Functional class

Uses

Dose and formulations

Dosage and routes

Available forms

teplizumab-­mzwv

Overview

Names and pronunciation

Functional class

Uses

Dose and formulations

Dosage and routes

Available forms

teplizumab-mzwv

teplizumab-mzwv